A detailed history of Wendell David Associates Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wendell David Associates Inc holds 32,885 shares of EW stock, worth $3.04 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
32,885
Previous 34,130 3.65%
Holding current value
$3.04 Million
Previous $2.6 Million 20.75%
% of portfolio
0.32%
Previous 0.28%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$72.54 - $95.56 $90,312 - $118,972
-1,245 Reduced 3.65%
32,885 $3.14 Million
Q4 2023

Jan 22, 2024

SELL
$61.71 - $77.76 $217,527 - $274,104
-3,525 Reduced 9.36%
34,130 $2.6 Million
Q3 2023

Oct 20, 2023

SELL
$69.28 - $93.38 $75,515 - $101,784
-1,090 Reduced 2.81%
37,655 $2.61 Million
Q2 2023

Jul 20, 2023

SELL
$81.41 - $94.33 $1.29 Million - $1.49 Million
-15,830 Reduced 29.01%
38,745 $3.66 Million
Q1 2023

Apr 19, 2023

SELL
$74.26 - $84.51 $766,734 - $872,565
-10,325 Reduced 15.91%
54,575 $4.52 Million
Q4 2022

Jan 17, 2023

SELL
$68.3 - $87.44 $413,898 - $529,886
-6,060 Reduced 8.54%
64,900 $4.84 Million
Q3 2022

Oct 18, 2022

SELL
$82.37 - $107.29 $29,653 - $38,624
-360 Reduced 0.5%
70,960 $5.86 Million
Q2 2022

Jul 14, 2022

SELL
$86.5 - $128.27 $17,732 - $26,295
-205 Reduced 0.29%
71,320 $6.78 Million
Q1 2022

Apr 22, 2022

SELL
$101.96 - $128.34 $124,900 - $157,216
-1,225 Reduced 1.68%
71,525 $8.42 Million
Q4 2021

Jan 24, 2022

BUY
$106.37 - $130.68 $257,947 - $316,899
2,425 Added 3.45%
72,750 $9.43 Million
Q3 2021

Oct 19, 2021

BUY
$102.91 - $122.75 $123,492 - $147,300
1,200 Added 1.74%
70,325 $7.96 Million
Q2 2021

Jul 19, 2021

BUY
$83.84 - $104.76 $366,800 - $458,325
4,375 Added 6.76%
69,125 $7.16 Million
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $212,829 - $245,262
2,705 Added 4.36%
64,750 $5.42 Million
Q4 2020

Jan 22, 2021

BUY
$71.69 - $91.23 $330,490 - $420,570
4,610 Added 8.03%
62,045 $5.66 Million
Q3 2020

Oct 20, 2020

BUY
$67.19 - $87.44 $919,495 - $1.2 Million
13,685 Added 31.28%
57,435 $4.58 Million
Q2 2020

Jul 17, 2020

BUY
$57.54 - $76.95 $1.8 Million - $2.4 Million
31,250 Added 250.0%
43,750 $3.02 Million
Q1 2020

Apr 16, 2020

BUY
$52.41 - $81.0 $11,792 - $18,225
225 Added 1.83%
12,500 $2.36 Million
Q4 2019

Jan 17, 2020

BUY
$71.7 - $82.09 $8,604 - $9,850
120 Added 0.99%
12,275 $2.86 Million
Q3 2019

Oct 22, 2019

BUY
$61.55 - $75.43 $3,385 - $4,148
55 Added 0.45%
12,155 $2.67 Million
Q2 2019

Jul 16, 2019

BUY
$55.74 - $64.41 $11,538 - $13,332
207 Added 1.74%
12,100 $2.24 Million
Q1 2019

Apr 11, 2019

BUY
$47.89 - $64.05 $20,257 - $27,093
423 Added 3.69%
11,893 $2.28 Million
Q4 2018

Jan 17, 2019

BUY
$46.41 - $56.94 $67,526 - $82,847
1,455 Added 14.53%
11,470 $1.76 Million
Q3 2018

Oct 12, 2018

BUY
$45.7 - $58.03 $21,341 - $27,100
467 Added 4.89%
10,015 $1.74 Million
Q2 2018

Jul 16, 2018

BUY
$42.45 - $51.3 $15,409 - $18,621
363 Added 3.95%
9,548 $1.39 Million
Q1 2018

Apr 11, 2018

BUY
$37.19 - $47.45 $97,995 - $125,030
2,635 Added 40.23%
9,185 $1.28 Million
Q4 2017

Jan 16, 2018

BUY
$33.79 - $39.39 $51,529 - $60,069
1,525 Added 30.35%
6,550 $738,000
Q3 2017

Oct 17, 2017

BUY
$36.29 - $38.83 $182,357 - $195,120
5,025
5,025 $549,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.